News
Asianet Newsable on MSN41m
Capricor Stock Slumps 16% On Report Of Key FDA Executive’s Removal, But Retail’s Hopeful About New 4-Year Deramiocel DataCapricor on Friday announced positive four-year safety and efficacy results from its ongoing mid-stage study of its cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback